Skip to content


Main research and commercialized activities:

Genom Kit  Progressive technology for the rationalization of personalized pharmacogenomics, nutrigenomics and sports medicine. Identification code no. FV30421
The effective biotechnology for population chip synthesis as well as its verification on the pilot plant material matrix. This project no. TH02010351 is co-financed by TA ČR.

The project is aimed at substantial innovation of biotechnological methods based on newly developed population chips, the application of which will enable spreading of the progressive technology in the sphere of biotechnologies and will make it possible to use more environmentally friendly populations of red clover that have been gained via detection of allele gene variants. Another output of the project rests in the legal protection of technology for red clover selection with improved nitrogen fixation. 
The technology used will be principally more economical and more focused towards protection of environment and will enhance a content of stable organic matter and will broaden functional diversity of microorganisms in soils. Economical and environmental evaluation will be provided.

Technology for destruction of persistent pollutants (POPDESTR)
Microarray quality control system (OLIGOSYNT)
Analytical inspection of quality of main precursors of PET Radiopharmaceuticals
Analytical identification of pigment vehicles in 19st-masterpiece of Prague theater curtain from Victor Tardos-Kranner using TLC, MALDI-TOF a GC/MS
Methodology development for rapid analysis and identification of poisonous substances in equine blood
Detection of genetic metabolism of disorders of pyrimidine using LC-MS
Development of analytical method for quantification of immunosupressants using LC-MS
Quantitative determination of trace metals (Cr, Hg, Pg, Cd, CrVI+), polybrominate, diphenyls and polybrominated diphenylethers using AAS, chromometry and APCI+/--MS
Qualitative and quantitative analysis and development of organic and inorganic disinfectant components using LC/MS, XRD, XRF and NMR
Cooperation in development of method in monitoring of inflammatory markers, biomarkers of oxidative stress, cysteinyl leukotriens and leukotriene B4 in breath condensate using LC-MS
Development of technology of 5-phenyl-1,3-dimethylbarbituric acid for production of activator to self-curing/autopolymerizating dental resins
Ames mutagenicity assays co-operated with Xenometrix